Literature DB >> 33372064

A stem cell based in vitro model of NAFLD enables the analysis of patient specific individual metabolic adaptations in response to a high fat diet and AdipoRon interference.

Nina Graffmann1, Audrey Ncube1, Soraia Martins1, Aurelian Robert Fiszl1, Philipp Reuther2, Martina Bohndorf1, Wasco Wruck1, Mathias Beller3,4, Constantin Czekelius2, James Adjaye5.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease. Its development and progression depend on genetically predisposed susceptibility of the patient towards several 'hits' that induce fat storage first and later inflammation and fibrosis. Here, we differentiated induced pluripotent stem cells (iPSCs) derived from four distinct donors with varying disease stages into hepatocyte like cells (HLCs) and determined fat storage as well as metabolic adaptations after stimulations with oleic acid. We could recapitulate the complex networks that control lipid and glucose metabolism and we identified distinct gene expression profiles related to the steatosis phenotype of the donor. In an attempt to reverse the steatotic phenotype, cells were treated with the small molecule AdipoRon, a synthetic analogue of adiponectin. Although the responses varied between cells lines, they suggest a general influence of AdipoRon on metabolism, transport, immune system, cell stress and signalling.
© 2021. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  AdipoRon; FGF21; Hepatocyte differentiation; Hepatocyte-like cells; Metabolism; NAFLD

Mesh:

Substances:

Year:  2021        PMID: 33372064      PMCID: PMC7860118          DOI: 10.1242/bio.054189

Source DB:  PubMed          Journal:  Biol Open        ISSN: 2046-6390            Impact factor:   2.643


  55 in total

1.  Linear models and empirical bayes methods for assessing differential expression in microarray experiments.

Authors:  Gordon K Smyth
Journal:  Stat Appl Genet Mol Biol       Date:  2004-02-12

2.  Characterization of iPSCs derived from dermal fibroblasts from a healthy 19year old female.

Authors:  Marie-Ann Kawala; Martina Bohndorf; Nina Graffmann; Wasco Wruck; Kurt Zatloukal; James Adjaye
Journal:  Stem Cell Res       Date:  2016-10-19       Impact factor: 2.020

Review 3.  Human fatty liver disease: old questions and new insights.

Authors:  Jonathan C Cohen; Jay D Horton; Helen H Hobbs
Journal:  Science       Date:  2011-06-24       Impact factor: 47.728

4.  Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α.

Authors:  Joseph S Marino; Lance A Stechschulte; David E Stec; Andrea Nestor-Kalinoski; Sydni Coleman; Terry D Hinds
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

5.  Characterization of dermal fibroblast-derived iPSCs from a patient with low grade steatosis.

Authors:  Marie-Ann Kawala; Martina Bohndorf; Nina Graffmann; Wasco Wruck; Kurt Zatloukal; James Adjaye
Journal:  Stem Cell Res       Date:  2016-10-20       Impact factor: 2.020

Review 6.  Adiponectin signaling in the liver.

Authors:  Terry P Combs; Errol B Marliss
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

Review 7.  Adiponectin: a versatile player of innate immunity.

Authors:  Yan Luo; Meilian Liu
Journal:  J Mol Cell Biol       Date:  2016-03-18       Impact factor: 6.216

8.  Perilipin discerns chronic from acute hepatocellular steatosis.

Authors:  Lena Maria Pawella; Merita Hashani; Eva Eiteneuer; Marcus Renner; Ralf Bartenschlager; Peter Schirmacher; Beate Katharina Straub
Journal:  J Hepatol       Date:  2013-11-19       Impact factor: 25.083

Review 9.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Authors:  Elena Buzzetti; Massimo Pinzani; Emmanuel A Tsochatzis
Journal:  Metabolism       Date:  2016-01-04       Impact factor: 8.694

10.  KEGG: new perspectives on genomes, pathways, diseases and drugs.

Authors:  Minoru Kanehisa; Miho Furumichi; Mao Tanabe; Yoko Sato; Kanae Morishima
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

View more
  4 in total

Review 1.  Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like Cells.

Authors:  Josef Blaszkiewicz; Stephen A Duncan
Journal:  Genes (Basel)       Date:  2022-03-24       Impact factor: 4.141

Review 2.  Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models.

Authors:  Abida Islam Pranty; Sara Shumka; James Adjaye
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

Review 3.  Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models.

Authors:  María Pelechá; Estela Villanueva-Bádenas; Enrique Timor-López; María Teresa Donato; Laia Tolosa
Journal:  Antioxidants (Basel)       Date:  2021-12-30

Review 4.  From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights.

Authors:  Alexandra Gatzios; Matthias Rombaut; Karolien Buyl; Joery De Kock; Robim M Rodrigues; Vera Rogiers; Tamara Vanhaecke; Joost Boeckmans
Journal:  Biomedicines       Date:  2022-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.